Breaking News, Collaborations & Alliances

Immunai Enters Collaboration with Teva focused on Immunology & Immuno-Oncology

Key focus areas will include drug mechanism of action, dose selection, and biomarker analyses.

Author Image

By: Charlie Sternberg

Associate Editor

Immunai Inc., an artificial intelligence (AI) biotech company specializing in mapping the human immune system, has entered a multi-year collaboration with Teva Pharmaceuticals, an affiliate of Teva Pharmaceutical Industries Ltd., under which it will collaborate with Teva in Immunology and Immuno-oncology programs.   This collaboration will leverage Immunai’s proprietary immune cell atlas, AMICA, and its AI model, the Immunodynamics Engine (IDE), to enhance clinical decision-making in Teva&#821...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters